Walgreens Boots Alliance (WBA) Expected to Announce Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) is projected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company's revenue for the quarter was up 7.6% on a year-over-year basis. During the same quarter last year, the business posted $0.66 EPS. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Up 0.3 %

Shares of NASDAQ WBA traded up $0.03 during mid-day trading on Friday, reaching $11.19. 12,142,307 shares of the company traded hands, compared to its average volume of 21,067,529. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company's fifty day moving average is $10.86 and its two-hundred day moving average is $9.88. The stock has a market cap of $9.67 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance has a fifty-two week low of $8.08 and a fifty-two week high of $22.05.

Remove Ads

Analyst Upgrades and Downgrades

WBA has been the subject of a number of analyst reports. Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a report on Monday, January 13th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a report on Wednesday. They set a "hold" rating on the stock. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Finally, Royal Bank of Canada boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.